Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents

    Lim, Jung Sub; Kim, Eun Young; Kim, Jae Hyun; Yoo, Jae-Ho; Yi, Kyung Hee; Chae, Hyun Wook; Choi, Jin-Ho; Kim, Ji Young; Hwang, Tae.
    Ann Pediatr Endocrinol Metab; 25 (4), 2020
    The Committee on Dyslipidemia of Korean Pediatric and Adolescents of the Korean Society of Pediatric Endocrinology has newly developed evidence-based clinical practice guidelines for dyslipidemia in Korean children and adolescents. These guidelines were formulated with the Grading of Recommendations, whi...
    Dislipidemias/prevención & control, Enfermedades Cardiovasculares/prevención & control, Conducta Alimentaria, República de Corea/epidemiología, Estilo de Vida, Factores de Riesgo, Aterosclerosis/prevención & control
    Texto completo

    Management of Dyslipidemia for cardiovascular disease risk Reduction: synopsis of the 2020 updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline

    O'Malley, Patrick G; Arnold, Michael J; Pharm, Cathy Kelley; Spacek, Lance; Buelt, Andrew; Natarajan, Sundar; Donahue, Mark P; Vagichev, Elena; Ballard-Hernandez, Jennifer; Logan, Amanda; Thomas, Lauren; Ritter, Joan; Neubauer, Brian E; Downs, John R.
    In June 2020, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) released a joint update of their clinical practice guideline for managing dyslipidemia to reduce cardiovascular disease risk in adults. This synopsis describes the major recommendations. The guideline panel de...
    Enfermedades Cardiovasculares/prevención & control, Enfermedades Cardiovasculares/diagnóstico, Dislipidemias/prevención & control, Dislipidemias/diagnóstico, Práctica Clínica Basada en la Evidencia, Rehabilitación Cardiaca, Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico
    Texto completo

    Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 U. S. Department of Veterans Affairs and U. S. Department of Defense clinical practice guideline

    Downs, J. R; O'Malley, P. G.
    Ann. intern. med; 163 (4), 2015
    DESCRIPTION: In December 2014, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of dyslipidemia for cardiovascular disease risk reduction in adults. This synopsis summarizes the major recommendations. METHODS...
    Enfermedades Cardiovasculares/diagnóstico, Dislipidemias, Pruebas Hematológicas, Inhibidores de Hidroximetilglutaril-CoA Reductasas, Conducta de Reducción del Riesgo, Prevención Secundaria
    Texto completo